[Federal Register: January 28, 2003 (Volume 68, Number 18)]
[Notices]               
[Page 4238-4239]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28ja03-110]                         


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE


Drug Enforcement Administration


 
Manufacture of Controlled Substances Notice of Registration


    By Notice dated June 18, 2002, and published in the Federal 
Register on


[[Page 4239]]


July 10, 2002, (67 FR 45765), Roche Diagnostics Corporation, ATTN: 
Regulatory Compliance, 9115 Hague Road, Indianapolis, Indiana 46250, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of the basic classes of 
controlled substances listed below:


------------------------------------------------------------------------
                   Drug                               Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide (7315).........  I
Tetrahydrocannabinols (7370)..............  I
Alphamethadol (9605)......................  I
Phencyclidine (7471)......................  II
Benzoylecgonine (9180)....................  II
Methadone (9250)..........................  II
Morphine (9300)...........................  II
------------------------------------------------------------------------


    Roche Diagnostics Corporation plans to manufacture small quantities 
of the above listed controlled substances for incorporation in drug of 
abuse detection kits.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, U.S.C., Sec.  823(a) and determined that the 
registration of Roche Diagnostics Corporation is consistent with the 
public interest at this time. DEA has investigated Roche Diagnostics 
Corporation on a regular basis to ensure that the company's continued 
registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, audits of the company's records, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history., Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic classes of controlled substances listed above 
is granted.


    Dated: January 6, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-1917 Filed 1-27-03; 8:45 am]

BILLING CODE 4410-09-M